论文部分内容阅读
一般进行经过 晚期血吸虫病的治疗一般是很困难的,患者常有脾机能亢进和门脉高压症等现象而他们的一般情况和肝功能(尤其是血浆蛋白’、方面的改变)都比较差,故于考虑作锑剂治疗,或进行脾截除、中门静脉分流术等手术时,都存在着一定错。“治疗血清”中含有一定温度的蛋白成分,并可进行静脉注射,因此我们选择了“治疗血清”作长期注射,目的在于观察“治疗血清”有无可能为治疗晚期血吸虫病创造有利条件,如改善机体营养状况等。自1956年10月起,我们先后收入此类病例计13人,进行“治疗血清”的长期注射,观
In general, treatment of advanced schistosomiasis is usually very difficult. Patients often have hypersplenism and portal hypertension and their general condition and liver function (especially plasma protein) are relatively poor. Therefore, considering antimony agent for treatment, or for splenectomy, portal vein shunt surgery, there are some wrong. The “therapeutic serum” contains protein components at a certain temperature and can be injected intravenously, so we chose “therapeutic serum” for long-term injections to see if “therapeutic serum” might create favorable conditions for the treatment of advanced schistosomiasis such as Improve the nutritional status of the body. Since October 1956, we have received 13 cases of such cases for long-term injections of “therapeutic serum”